See also: Clinical Trial
NCT00256750 is belatacept evaluation of nephroprotection and efficacy as first-line immunosuppression trial. Other study IDs include: IM103-008, BENEFIT.
Reported purpose & perceived effectiveness
- Can't tell
Side effects as an overall problem
Commonly reported side effects and conditions associated with Kidney Transplant Phase 3 Belatacept BENEFIT
Cost per month